HIV News and Research

RSS

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

Tracking the mutating coronavirus variants

Viruses continuously and naturally evolve. To track coronavirus variants, we need to think like Darwin.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

UC San Diego receives $38 million USAID grant to address gender equity and health issues

The U.S. Agency for International Development has funded a $38 million, five-year project led by the Center on Gender Equity and Health at University of California San Diego School of Medicine and Herbert Wertheim School of Public Health and Human Longevity Science.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Researchers demonstrate enhanced loss-of-function editing of CRISPR/Cas9 in human cells.

14 Mar 2022

Canadian scientist discusses about how society could better prepare for future pandemics

Aled Edwards is of two minds about medicine's response to COVID-19. On one hand, he notes, we had life-saving vaccines and therapies less than a year after the discovery of SARS-CoV-2. On the other, more than six million, and possibly as many as 18 million people have died, and global access to advances that can prevent and treat severe disease remains highly inequitable.

11 Mar 2022

Shorter treatment for children with non-severe tuberculosis

A UCL-led international trial exploring the effectiveness of tuberculosis (TB) treatment in children has led to a change in the World Health Organisation's global guidelines for managing the disease.

10 Mar 2022

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Sexual partnerships between individuals from different communities may help explain why some community-based HIV prevention efforts were moderately effective, shows a study published in eLife.

8 Mar 2022

Young people who stop using drugs can have high levels of life success in adulthood

Young people who stop using cannabis or amphetamines before becoming adults experience life success at the same levels of those who have never used drugs, according to a University of Queensland study.

8 Mar 2022

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes save time and improve lab productivity, and the company has created a testimonial video showcasing the pipette’s many useful features.

From INTEGRA Biosciences 8 Mar 2022

Relationship between immunological responses in the acute phase of SARS-CoV-2 infection and long-term cognitive deficits

A recent study reported that monocytosis during the acute phase of coronavirus disease 2019 could forecast anosognosia in long COVID.

8 Mar 2022

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases--enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

7 Mar 2022

GlyNAC supplementation can increase lifespan and improve multiple age-associated defects

Many people aspire to live longer, healthier lives. A researcher at Baylor College of Medicine, Dr. Rajagopal Sekhar, associate professor of medicine in the section of endocrinology, diabetes and metabolism, has been studying aging for the past 20 years to better understand its biological underpinnings and develop nutritional strategies to promote healthy aging.

7 Mar 2022

HIV News and Research

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

Tracking the mutating coronavirus variants

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

New way to deliver potential HIV vaccine using mRNA technology

High doses of antibiotic may safely and effectively treat TB meningitis

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

UC San Diego receives $38 million USAID grant to address gender equity and health issues

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Canadian scientist discusses about how society could better prepare for future pandemics

Shorter treatment for children with non-severe tuberculosis

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Young people who stop using drugs can have high levels of life success in adulthood

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

Relationship between immunological responses in the acute phase of SARS-CoV-2 infection and long-term cognitive deficits

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

GlyNAC supplementation can increase lifespan and improve multiple age-associated defects

Charts paint a grim picture 2 years into the coronavirus pandemic

Additional doses of covid-19 vaccine recommended for immunocompromised patients

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News